Research programme: HIV infection monoclonal antibodies - Enzolytics
Latest Information Update: 29 Dec 2021
Price :
$50 *
At a glance
- Originator Enzolytics
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research HIV infections
Most Recent Events
- 27 Oct 2021 Enzolytics has patents pending for methods for producing monoclonal antibodies (Enzolytics website, October 2021)
- 07 Oct 2021 Early research in HIV infections in USA (Parenteral)
- 07 Oct 2021 Enzolytics announces intention to submit IND for HIV infections